Brief: Accuray Receives FDA Clearance For Vitalhold On The Radixact System Breast Cancer Treatment Option Will Also Be Available In The EU Market
10/08/2023 01:16
Aug 9 (Reuters) - Accuray Inc ARAY.O :
* ACCURAY RECEIVES FDA CLEARANCE FOR VITALHOLD™ ON THE
RADIXACT®
SYSTEM; BREAST CANCER TREATMENT OPTION WILL ALSO BE AVAILABLE IN
THE EU MARKET
Source text for Eikon: ID:nPn1ghl7La
Further company coverage: ARAY.O
((Reuters.Briefs@thomsonreuters.com;))